Swiss National Bank’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-253,400
| Closed | -$13.3M | – | 2551 |
|
|
2020
Q3 | $13.3M | Buy |
253,400
+4,700
| +2% | +$195K | 0.01% | 709 |
|
|
2020
Q2 | $8.27M | Buy |
248,700
+28,700
| +13% | +$914K | 0.01% | 862 |
|
|
2020
Q1 | $5.98M | Buy |
220,000
+3,500
| +2% | +$97.4K | 0.01% | 837 |
|
|
2019
Q4 | $4.27M | Buy |
216,500
+40,600
| +23% | +$649K | ﹤0.01% | 1264 |
|
|
2019
Q3 | $2.28M | Buy |
175,900
+1,800
| +1% | +$21.7K | ﹤0.01% | 1582 |
|
|
2019
Q2 | $2.17M | Buy |
174,100
+7,900
| +5% | +$105K | ﹤0.01% | 1648 |
|
|
2019
Q1 | $2.42M | Buy |
166,200
+3,600
| +2% | +$46K | ﹤0.01% | 1551 |
|
|
2018
Q4 | $1.79M | Buy |
162,600
+34,000
| +26% | +$473K | ﹤0.01% | 1647 |
|
|
2018
Q3 | $3.38M | Buy |
128,600
+3,000
| +2% | +$81.1K | ﹤0.01% | 1378 |
|
|
2018
Q2 | $2.57M | Hold |
125,600
| – | – | ﹤0.01% | 1543 |
|
|
2018
Q1 | $2.28M | Buy |
125,600
+2,300
| +2% | +$38.3K | ﹤0.01% | 1548 |
|
|
2017
Q4 | $1.72M | Buy |
123,300
+7,600
| +7% | +$103K | ﹤0.01% | 1731 |
|
|
2017
Q3 | $2.14M | Hold |
115,700
| – | – | ﹤0.01% | 1581 |
|
|
2017
Q2 | $1.96M | Buy |
115,700
+5,600
| +5% | +$85.2K | ﹤0.01% | 1605 |
|
|
2017
Q1 | $1.47M | Hold |
110,100
| – | – | ﹤0.01% | 1781 |
|
|
2016
Q4 | $1.66M | Hold |
110,100
| – | – | ﹤0.01% | 1699 |
|
|
2016
Q3 | $1.29M | Sell |
110,100
-3,600
| -3% | -$42.3K | ﹤0.01% | 1812 |
|
|
2016
Q2 | $1.23M | Buy |
113,700
+2,300
| +2% | +$23.7K | ﹤0.01% | 1843 |
|
|
2016
Q1 | $995K | Buy |
111,400
+19,900
| +22% | +$214K | ﹤0.01% | 1893 |
|
|
2015
Q4 | $1.36M | Buy |
91,500
+2,300
| +3% | +$38.5K | ﹤0.01% | 1593 |
|
|
2015
Q3 | $1.46M | Buy |
89,200
+10,600
| +13% | +$217K | ﹤0.01% | 1510 |
|
|
2015
Q2 | $1.79M | Buy |
78,600
+21,100
| +37% | +$420K | ﹤0.01% | 1385 |
|
|
2015
Q1 | $874K | Buy |
57,500
+2,200
| +4% | +$28.6K | ﹤0.01% | 1832 |
|
|
2014
Q4 | $666K | Hold |
55,300
| – | – | ﹤0.01% | 1990 |
|
|
2014
Q3 | $627K | Hold |
55,300
| – | – | ﹤0.01% | 1950 |
|
|
2014
Q2 | $668K | Hold |
55,300
| – | – | ﹤0.01% | 1974 |
|
|
2014
Q1 | $644K | Buy |
55,300
+11,100
| +25% | +$188K | ﹤0.01% | 1987 |
|
|
2013
Q4 | $781K | Hold |
44,200
| – | – | ﹤0.01% | 1709 |
|
|
2013
Q3 | $636K | Hold |
44,200
| – | – | ﹤0.01% | 1785 |
|
|
2013
Q2 | $666K | Buy |
+44,200
| New | +$583K | ﹤0.01% | 1714 |
|
Swiss National Bank's MNTA Position: Q4 2020 in Review
Swiss National Bank sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 253,400 shares — an estimated $13.3M sold.
Swiss National Bank first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $13.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Swiss National Bank reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Swiss National Bank sold 253,400 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $13.3M.
- Swiss National Bank first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Swiss National Bank's Momenta Pharmaceuticals, Inc. position peaked at $13.3M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Swiss National Bank's 13F filing for Q4 2020, filed 5 Feb 2021.